Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Central neuropeptides play important roles in many instances of physiological and pathophysiological regulation mediated through the autonomic nervous system. In regard to the hepatobiliary system, several neuropeptides act in the brain to regulate bile secretion, hepatic blood flow, and hepatic proliferation. Stressors and sympathetic nerve activation are reported to exacerbate experimental liver injury. Some stressors are known to stimulate
corticotropin-releasing factor
(
CRF
) synthesis in the central nervous system and induce activation of sympathetic nerves in animal models. The effect of intracisternal
CRF
on carbon tetrachloride (CCl4)-induced acute liver injury was examined in rats. Intracisternal injection of
CRF
dose dependently enhanced elevation of the serum alanine aminotransferase (ALT) level induced by CCl4. Elevations of serum
aspartate aminotransferase
, alkaline phosphatase, and total bilirubin levels by CCl4 were also enhanced by intracisternal
CRF
injection. Intracisternal injection of
CRF
also aggravated CCl4-induced hepatic histological changes. Intracisternal
CRF
injection alone did not modify the serum ALT level. Intravenous administration of
CRF
did not influence CCl4-induced acute liver injury. The aggravating effect of central
CRF
on CCl4-induced acute liver injury was abolished by denervation of hepatic plexus with phenol and by denervation of noradrenergic fibers with 6-hydroxydopamine treatment but not by hepatic branch vagotomy or atropine treatment. These results suggest that
CRF
acts in the brain to exacerbate acute liver injury through the sympathetic-noradrenergic pathways.
...
PMID:Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats. 1007 38
The effect of intracisternal injection of urocortin, an endogenous ligand for
corticotropin-releasing factor
(
CRF
) 2 receptor, on carbon tetrachloride (CCl4)-induced acute liver injury was investigated in rats. Intracisternal injection of urocortin dose-dependently enhanced elevation of serum alanine aminotransferase and
aspartate aminotransferase
levels induced by CCl4. Intracisternal urocortin also aggravated CCl4-induced histological changes of the liver. The aggravating effect of central urocortin on CCl4-induced acute liver injury was abolished by chemical sympathectomy, but not by vagotomy. These data demonstrate that urocortin acts in the brain to exacerbate acute liver injury through the sympathetic nervous system and suggest a possible involvement of the CRF2 receptor in the central
CRF
-induced exacerbation of acute liver injury in rats.
...
PMID:Effect of central urocortin on carbon tetrachloride-induced acute liver injury in rats. 1168 49
Central neuropeptides play important roles in many physiological and pathophysiological regulation mediated through the autonomic nervous system. In regard to the hepatobiliary system, several neuropeptides act in the brain to regulate bile secretion, hepatic blood flow, and hepatic proliferation. Central injection of
corticotropin-releasing factor
(
CRF
) aggravates carbon tetrachloride (CCl4)-induced acute liver injury through the sympathetic nervous pathway in rats. However, still nothing is known about a role of endogenous neuropeptides in the brain in hepatic pathophysiological regulations. Involvement of endogenous
CRF
in the brain in CCl4-induced acute liver injury was investigated by centrally injecting a
CRF
receptor antagonist in rats. Male fasted Wistar rats were injected with
CRF
receptor antagonist alpha-helical
CRF
-(9-41) (0.125-5 microg) intracisternally just before and 6 h after CCl4 (2 ml/kg) administration, and blood samples were obtained before and 24 h after CCl4 injection for measurement of hepatic enzymes. The liver sample was removed 24 h after CCl4 injection, and histological changes were examined. Intracisternal alpha-helical
CRF
-(9-41) dose dependently (0.25-2 microg) reduced the elevation of alanine aminotransferase and
aspartate aminotransferase
levels induced by CCl4. Intracisternal alpha-helical
CRF
-(9-41) reduced CCl4-induced liver histological changes, such as centrilobular necrosis. The effect of central
CRF
receptor antagonist on CCl4-induced liver injury was abolished by sympathectomy and 6-hydroxydopamine pretreatment but not by hepatic branch vagotomy or atropine pretreatment. These findings suggest the regulatory role of endogenous
CRF
in the brain in experimental liver injury in rats.
...
PMID:Involvement of endogenous CRF in carbon tetrachloride-induced acute liver injury in rats. 1201 Jul 61